Item request has been placed!
×
Item request cannot be made.
×
Processing Request
HEART OF THE MATTER.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Subject Terms:
- Abstract:
The article offers information on the clinical trials of Mexiletine, a drug approved by the U.S. Food and Drug Administration (FDA) for heart rhythm abnormalities, to evaluate its safety and tolerability in amyotrophic lateral sclerosis (ALS) patients who are 18 years of age.
No Comments.